McElroy SL, Kemp DE, Friedman ES, Reilly-Harrington NA, Sylvia LG, Calabrese JR, Rabideau DJ, Ketter TA, Thase ME, Singh V, Tohen M, Bowden CL, Bernstein EE, Brody BD, Deckersbach T, Kocsis JH, Kinrys G, Bobo WV, Kamali M, McInnis MG, Leon AC, Faraone S, Nierenberg AA, Shelton RC (2015). Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder. Acta Psychiatrica Scandinavica, (in press).
Cropsey, K.L., Clark, C.B., Hendricks, P.S. (2015). Effect of varenicline on smoking cessation through smoking reduction: A randomized clinical trial. Letter to the editor. Journal of the American Medical Association, 22, 2284-2285.
Kippe JM, Mueller TM, Haroutunian V, and Meador-Woodruff JH: Abnormal N-Acetylglucosaminyltransferase Expression in Prefrontal Cortex in Schizophrenia. Schizophrenia Research. In press.
Mueller TM, Remedies CE, Haroutunian V, and Meador-Woodruff JH:  Abnormal Subcellular Localization of GABAA Receptor Subunits in Schizophrenia Brain.  Translational Psychiatry. In press.

Libero L, DeRamus T, Lahti AC, Deshpande G, Kana R: Multimodal neuroimaging based classification of autism spectrum disorder using anatomical, neurochemical and white matter correlates. Cortex. In press.
Robert SM, Buckingham SC, Campbell SL, Robel S, Holt KT, Ogunrinu-Babarinde T, Warren PP, White DM, Reid MA, Eschbacher JM, Berens ME, Lahti AC, Nabors LB, Sontheimer H: SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma. Science Translational Medicine. In press.
Dean B, Gibbons AS, Boer S, Uezato A, Meador-Woodruff JH, Scarr E, and McCullumsmith RE:  Changes in Cortical N-Methyl-D-Aspartate Receptors and Postsynaptic Density Protein 95 in Schizophrenia, Mood Disorders and Suicide. Australian and New Zealand Journal of Psychiatry.  In press.
Fournier JC, DeRubeis RJ, Amsterdam J, Shelton RC, Hollon SD: Gains in employment status following antidepressant medication or cognitive therapy for depression. British Journal of Psychiatry 206:332–338, 2015
Papakostas GI, Fava M, Baer L, Swee MB, Jaeger A, Bobo WV, Shelton RC: Ziprasidone augmentation of escitalopram for major depressive disorder: efficacy results from a randomized, double-blind, placebo-controlled study. Am J Psychiatry (in press).
O’Donovan SM, Hasselfeld K, Bauer D, Simmons M, Roussos P, Haroutunian V, Meador-Woodruff JH, and McCullumsmith RE:  Glutamate Transporter Splice Variant Expression in an Enriched Pyramidal Cell Population in Schizophrenia.  Translational Psychiatry. In press.